As Measles cases continue to rise across Pennsylvania, concerns are also growing within the medical profession, with the state’s Department of Health now promoting something called a ‘Titer ...

A large study of historically smallpox-vaccinated individuals finds residual but uneven immunity, with chronic disease and ...

If you are hoping to become pregnant, you should check your rubella vaccination history and antibody test results before pregnancy. If vaccination is necessary, it is important to discuss it with your ...

A case report details a 38-year-old woman whose anti-U1-RNP-positive inflammatory myopathy went undiagnosed for six years ...

Healthbeat reports colleges urge faculty and staff to prove measles immunity to prevent disruptions from outbreaks, ...

Doctors warn that about 38% to 40% of measles cases this year have been in adults. Here’s what you need to know.

At the first visit, patients sometimes say, "I was surprised by the amount of blood drawn." It is not uncommon for 6 to 8 ...

Invivyd (NASDAQ:IVVD) reported topline results from its Phase III LIBERTY study of VYD2311, an investigational low-dose intramuscular monoclonal antibody designed to prevent COVID-19, and outlined ...

The CellTiter-Glo ® 2.0 Cell Viability Assay is a luminescent method for swift, convenient, routine cell viability assessments. Offers equivalent performance to the classic CellTiter-Glo ® Cell ...

Recognition of mixed autoimmune hemolytic anemia can help clinicians avoid treatment strategies appropriate for only warm or cold disease.

About LIBERTY LIBERTY is a Phase 3, randomized, double-blind clinical trial to evaluate the safety, serum virus neutralizing antibody responses, and pharmacokinetics of VYD2311, an mRNA COVID vaccine, ...